Psilocybin as a new way for depression treatment
Mateusz Pawlicki, Aleksandra Kłos, Karol Stachyrak, Dawid Mika, Bartosz Mazur, Kamila Turek, Maciej Lambach, Anna Gregułą, Aleksandra Mazurek, Wiktoria Wilanowska
Journal of Education Health and Sport May 15, 2024 DOI: 10.12775/jehs.2024.68.50168 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Population | Patients with major depressive disorders or serious life-threatening conditions |
| Topics | Psilocybin Depression |
| Keywords | Depression economics Hallucinogen Psychotherapist Keynesian economics |
| Key findings | Psilocybin lowers depression and anxiety scores in patients with major depressive disorders or serious life-threatening conditions, with long-lasting effects and little or no adverse side effects. |
Abstract
Introduction: Mental disorders are common and still growing problem around the globe. Significantly decreasing quality of life, they are often source of true suffering for patients and their families leading to further health issues or even dramatic outcomes resulting in death. As public awareness rises, more and more people understand risks and tend to look for help as fast as possible. Currently available treatment methods are not always efficient enough to deal with more complex cases. Therefore it is important to look for new therapy options incrementing chances of fast and successful treatment.
Results: Studies showed that psilocybin is not only able to lower depression and anxiety scores in patients with major depressive disorders or with serious life-threatening conditions but also proved this effect to be long-lasting. At the same time, no or little adverse side effects were noticed.
Conclusions: Psilocybin is potentially a good method for depression treatment in some groups of patients. It should be considered if other, better known therapies show little or no effects.